Related Experiment Video
Updated: Jul 31, 2026
09:22
Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Thin-walled ring shadows in early pulmonary sarcoidosis
Clinical Radiology
|July 1, 1984
Summary
Thin-walled ring shadows in early sarcoidosis, unlike typical fibrotic changes, may resolve with corticosteroid treatment. This suggests a potentially reversible cause related to granuloma necrosis and airway obstruction.
Area of Science:
- Pulmonary Medicine
- Radiology
- Immunology
Background:
- Ring shadows on chest radiographs in sarcoidosis typically indicate advanced, irreversible pulmonary fibrosis.
- Understanding early radiographic findings is crucial for timely diagnosis and management.
Observation:
- Three patients with sarcoidosis presented with early, thin-walled ring shadows on chest radiographs.
- These shadows were observed in areas with pre-existing lung shadowing.
Findings:
- In two of the three patients, these early ring shadows resolved with corticosteroid therapy over 1-2 years.
- The study proposes these shadows result from central necrosis of coalescent granulomas and a check-valve airway obstruction mechanism.
Implications:
- Early ring shadows may represent a distinct, potentially reversible manifestation of sarcoidosis.
- This finding could lead to earlier intervention and improved patient outcomes in pulmonary sarcoidosis.
Related Concept Videos
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...